Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues

British Journal of Pharmacology

Volumn 117, Issue 3, 1996, Pages 493-501

  Gouardères, Christine ^a   Jhamandas, Khem ^b   Sutak, Maaja ^b   Zajac, Jean Marie ^b  

^a CNRS   (France)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Intrathecal; Neuropeptide FF; Nociception; Rat spinal cord; and opioids

Indexed keywords

BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; DELTORPHIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; NEUROPEPTIDE FF; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG POTENTIATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030063463     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15217.x     Document Type: Article

References (66)

1. ALLARD, M., GEOFFRE, S., LEGENDRE, P., VINCENT, J.D. & SIMONNET, G. (1989). Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res., 500, 169-176.
2. ALLARD, M., JORDAN, D., ZAJAC, J.-M., RIS, C., MARTIN, D., MONKOUANGA, D., KOPP, N. & SIMONNET, G. (1994). Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res., 633, 127-132.
3. ALLARD, M., THEODOSIS, D.T., ROUSSELOT, P., LOMBARD, M.C. & SIMONNET, G. (1991). Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: biochemical and immunocytochemical studies. Neuroscience. 40, 81-92.
4. ALLARD, M., ZAJAC, J.-M. & SIMONNET, G. (1992). Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system, Neuroscience, 49, 101-116.
5. CALCAGNETTI, D.J. & HOLTZMAN, S.G. (1991). Delta opioid antagonist, naltrindole, selectivity blocks analgesia induced by DPDPE but not DAGO or morphine. Pharmacol. Biochem. Behav., 39, 185-190.
6. D'AMOUR, F.E. & SMITH, D.C. (1941). A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72, 74-79.
7. 2-like peptide, blocks opiate effects on ileum contractions. Peptides, 14, 1005-1009.
8. DESPRAT, C. & ZAJAC, J.-M. (1994). Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Dev. Brain Res., 82, 118-126.
9. DEVILLERS, J.P., MAZARGUIL, H., ALLARD, M., DICKENSON, A.H., ZAJAC, J.-M. & SIMONNET, G. (1994). Characterization of a potent agonist for NPFF receptors: binding study on rat spinal cord membranes. Neuropharmacology, 33, 661-669.
10. 5] enkephalin in the rat. J. Pharmacol. Exp. Ther., 259, 725-731.
11. 2]Deltorphin I: a high affinity, delta-selective opioid receptor ligand. Peptides, 121, 825-830.
12. DUPOUY, V. & ZAJAC, J.-M. (1995). Local interaction between neuropeptide FF and opioid systems into the nucleus raphe dorsalis. Regul. Pept. (in press).
13. FADEN, A.I. & JACOBS, T.P. (1984). Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action. Br. J. Pharmacol., 81, 271-276.
14. GICQUEL, S., FIORAMONTI, J., BUENO, L. & ZAJAC, J.-M. (1993). Effects of F8Famide analogues on intestinal transit in mice. Peptides, 14, 749-753.
15. GICQUEL, S., MAZARGUIL, H., ALLARD, M., SIMONNET, G. & ZAJAC, J.-M. (1992). Analogues of F8Famide resistant to degradation, possessing high affinity and in vivo effects. Eur. J. Pharmacol., 222, 61-67.
16. 125I]FK-33824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats. Neuroscience, 43, 197-209.
17. GOUARDERES, C., CROS, J. & QUIRION, R. (1985). Autoradiographic localization of mu, delta and kappa opioid receptor binding sites in rat and guinea-pig spinal cord. Neuropeptides, 6, 331-342.
18. GOUARDERES, C., JHAMANDAS, K., CRIDLAND, R., CROS, J., QUIRION, R. & ZAJAC, J.-M. (1993a). Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone. Neuroscience, 54, 799-807.
19. GOUARDERES, C., KAR, S., TAFANI, J.A.M., MARTIAL, J., QUIRION, R. & ZAJAC, J.-M. (1993b). Cellular localization of F8Famide receptors in the spinal cord evidenced by quantitative autoradiography following chemical and surgical deafferentation. Soc. Neurosci. Abstr., 19, 1563.
20. GOUARDERES, C., SUTAK, M., ZAJAC, J.-M. & JHAMANDAS, K. (1993c). Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol., 237, 73-81.
21. 2]Deltorphin I. Synapse, 13, 231-240.
22. 2 (CTOP) in mice. Eur. J. Pharmacol., 150, 355-360.
23. GUZMAN, A., LEGENDRE, P., ALLARD, M., GEOFFRE, S., VINCENT, J.D. & SIMONNET, G. (1989). Electrophysiological effects of FLFQPQRFamide, an endogenous brain morphine modulating peptide, on cultured mouse spinal cord neurons. Neuropeptides, 14, 253-261.
24. KAVALIERS, M. (1990). Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine and stress-induced analgesia in mice. Neurosci. Lett., 115, 307-312.
25. KAVALIERS, M. & COLWELL, D.D. (1993). Neuropeptide FF (FLQPQRFamide) and IgG from neuropeptide FF antiserum affect spatial learning in mice. Neurosci. Lett., 157, 75-78.
26. 2-related peptides augments morphine and stress-induced analgesia in mice. Peptides, 10, 741-745.
27. KIVIPELTO, L., MAJANE, E.A., YANG, H.-Y.T. & PANULA, P. (1989). Immunohistochemical distribution and partial characterization of FLFQPQRFamide-like peptides in the central nervous system of rats. J. Comp. Neurol., 286, 269-287.
28. KIVIPELTO, L. & PANULA, P. (1991a). Central neuronal pathways containing FLFQPQRFamide-like (morphine-modulating) peptides in the rat brain. Neuroscience, 41, 137-148.
29. KIVIPELTO, L. & PANULA, P. (1991b). Origin and distribution of neuropeptide FF-like immunoreactivity in the spinal cord of rats. J. Comp. Neurol., 307, 107-119.
30. KIVIPELTO, L., RUBENSTEIN, J., YANG, H.-Y.T. & PANULA, P. (1991). Ontogeny of the F8Famide-like (morphine-modulating) peptides in the central nervous system of rats. J. Comp. Neurol., 304, 14-33.
31. KREAM, R.M., KATO, T., SHIMONAKA, H., MARCHAND, J.E. & WURM, W.H. (1993). Substance P markedly potentiates the antinociceptive effects of morphine sulfate administered at the spinal level. Proc. Natl. Acad. Sci. U.S.A., 90, 3564-3568.
32. KURAISHI, Y., HARADA, Y., ARATANI, S., SATOH, M. & TAKAGI, H. (1983). Separate involvement of the spinal noradrenergic and serotoninergic systems in morphine analgesia: the differences in mechanical and thermal analgesic tests. Brain Res., 273, 245-252.
33. KURAISHI, Y., HIROTA, N., SATO, Y., HINO, Y., SATOH, M. & TAKAGI, H. (1985a). Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Res., 325, 294-298.
34. KURAISHI, Y., HIROTA, N., SATOH, M. & TAKAGI, H. (1985b). Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in the rats: mechanical and thermal analgesic tests. Bruin Res., 326, 168-171.
35. LAKE, J.R., HEBERT, K.M., PAYZA, K., DESHOTEL, K.D., HAUSAM, D.D., WITHERSPOON, W.E., ARCANGELI, K.A.R. & MALIN, D.H. (1992). Analog of neuropeptide FF attenuates morphine tolerance. Neurosci. Lett., 146, 203-206.
36. LOOMIS, C.W., CERVENKO, F.W., JHAMANDAS, K., SUTAK, M. & MILNE, B. (1985). Analgesia and autonomic function following intrathecal administration of morphine and norepinephrine to the rat. Can. J. Physiol. Pharmacol., 63, 656-662.
37. LOOMIS, C.W., MILNE, B. & CERVENKO, F.W. (1987). Determination of cross tolerance in rat spinal cord using intrathecal infusion via sequential mini-osmotic pumps. Pharmacol. Biochem. Behav., 26, 131-139.
38. 2 with μ and δ opioid antinociception in the rat spinal cord. Neuropeptides, 16, 213-218.
39. 2-like peptide. Brain Res., 494, 1-12.
40. MALIN, D.H., LAKE, J.R., ARCANGELI, K.A.R., DESHOTEL, K.D., HAUSAM, D.D., WITHERSPOON, W.E., CARTER, V.A., YANG, H.-Y.T., PAL, B. & BURGESS, K. (1993). Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome. Life Sci., 53, PL 261-266.
41. 2 like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides, 11, 969-972.
42. MALIN, D.H., LAKE, J.R., LEYVA, J.E., HAMMOND, M.V., ROGILLIO, R.B., ARCANGELI, K.A.R., LUDGATE, K., MOORE, G.M. & PAYZA, K. (1991). Analog of ncuropeptide FF attenuates morphine abstinence syndrome. Peptides, 12, 1011-1014.
43. MATTIA, A., FARMER, S.C., TAKEMORI, A.E., SULTANA, M., PORTOGHESE, P.S., MOSBERG, H.I., BOWEN, W.D. & PORRECA, H. (1992). Spinal opioid delta antinociception in the mouse: mediation by a 5′-NTII-sensitive delta receptor subtype. J. Pharmacol. Exp. Ther., 260, 518-525.
44. 2 analogues on intestinal motility and nociception in rats. J. Pharmacol. Exp. Ther., 265, 96-102.
45. MJANGER, E. & YAKSH, T.L. (1991). Characterization of dose-dependent antagonism by β-Funaltrexamine of the antinociceptive effects of intrathecal mu agonists. J. Pharmacol. Exp. Ther., 258, 544-550.
46. OBERLING, P., STINUS, L., LEMOAL, M. & SIMONNET, G. (1993). Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides, 14, 919-924.
47. OMOTE, K., KITAHATA, L.M., COLLINS, J.G., NAKATANI, K. & NAKAGAWA, I. (1990). The antinociceptive role of μ- and δ-opiate receptors and their interactions in the spinal dorsal horn of cats. Anesth. Analg., 71, 23-28.
48. OMOTE, K., KITAHATA, L.M., NAKATANI, K. & COLLINS, J.G. (1991). δ receptor involvement in morphine suppression of noxiously evoked activity in spinal WDR neurons in cats. Brain Res., 554, 299-303.
49. PAYZA, K., AKAR, C.A. & YANG, H.-Y.T. (1993). Neuropeptide FF receptors: structure-activity relationship and effect of morphine. J. Pharmacol. Exp. Ther., 267, 88-94.
50. PORTOGHESE, P.S., SULTANA, M. & TAKEMORI, A.E. (1988). Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur. J. Pharmacol., 146, 185-186.
51. 2), inhibit colonic head expulsion time in mice. Peptides, 10, 873-875.
52. 2 peptides on mouse colonie propulsive motility; a structure-activity relationship study. J. Pharmacol. Exp. Ther., 254, 809-814.
53. 2b receptors. Peptides, 15, 401-404.
54. RIVLIN, A.S. & TATOR, C.H. (1977). Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg., 47, 577-581.
55. 2 antiscrum. Neuropeptides, 10, 37-42.
56. ROTHMAN, R.B. (1992). A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse, 12, 129-138.
57. 2 (NPFF), down regulates mu opioid binding sites in rat brain. Peptides, 14, 1271-1277.
58. 2-adrenergic antinociception in the rat dorsal horn in vivo. Brain Res., 562, 327-328.
59. TISEO, P.J. & YAKSH, T.L. (1993). Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for δ-opioid receptor subtypes in the rat. Eur. J. Pharmacol., 236, 89-96.
60. TUNG, A.S. & YAKSH, T.I., (1982). In vivo evidence for multiple opiate receptors mediating analgesia in rat spinal cord. Brain Res., 247, 75.
61. WASOWICZ, K. & PANULA, P. (1994). Distribution of NPFF in porcine spinal cord in comparison with other neuropeptides and serotonin. J. Comp. Neurol., 346, 530-540.
62. YAKSH, T.L. & RUDY, T.A. (1976). Chronic catheterization of spinal subarachnoid space. Physiol. Behav., 17, 1031-1036.
63. YANG, H.-Y.T., FRATTA, W., MAJANE, E.A. & COSTA, E. (1985). Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. U.S.A., 82, 7757-7761.
64. YOBURN, B.C., BILLINGS, B. & DUTTAROY, A. (1993). Opioid receptor regulation in mice. J. Pharmacol. Exp. Ther., 265, 314-320.
65. ZHU, J., JHAMANDAS, K. & YANG, H.-Y.T. (1992). Release of neuropeptitle FF (FLFQPQRFamide) from rat spinal cord. Brain Res., 592, 326-332.
66. ZIMMERMAN, D.M., LEANDER, J.D., REEL, J.K. & HYNES, M.D. (1987). Use of β-Funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands. J. Pharmacol. Exp. Ther., 241, 374-378.